Robert Belvis

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Journal: The journal of headache and pain

Published: October 31, 2025

Is headache training improving during neurology residency in Spain? A ten-year comparative study from the dual perspective of residents and tutors.

Is headache training improving during neurology residency in Spain? A ten-year comparative study from the dual perspective of residents and tutors.

Journal: Neurologia

Published: July 16, 2025

Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine".

Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine".

Journal: Headache

Published: May 18, 2025

Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.

Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.

Journal: Frontiers in neurology

Published: April 15, 2024

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group.

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group.

Journal: Neurologia

Published: March 02, 2024

Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine.

Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine.

Journal: Headache

Published: January 22, 2024

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

Journal: Revista de neurologia

Published: January 15, 2024

Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment

Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment

Journal: Medicina clinica

Published: September 28, 2023

RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine.

RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine.

Journal: European journal of neurology

Published: August 30, 2023

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Journal: The journal of headache and pain

Published: February 09, 2023

Inequity of access to new migraine treatments.

Inequity of access to new migraine treatments.

Journal: Neurologia

Published: July 19, 2022

Cutaneous Allodynia in Migraine: A Narrative Review.

Cutaneous Allodynia in Migraine: A Narrative Review.

Journal: Frontiers in neurology

Published: December 07, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026